Canada’s Drug Agency (CDA-AMC) is an independent not-for-profit health care organization that provides Canada’s federal, provincial, and territorial health care decision makers with credible, impartial advice and evidence-based information about the effectiveness and efficiency of drugs and health technologies. In addition to evidence and advice, CDA-AMC also provides recommendations and tools.
On December 18th, 2023, the federal government announced the creation of Canada’s Drug Agency (CDA-AMC) by building on the foundation of CADTH and in partnership with provinces and territories. With the creation of the CDA-AMC, the organization now has emerging areas of focus—in addition to its core work on HTAs and clinical and cost effectiveness of new drugs—which include appropriate prescribing and use, data and analytics, and system coordination. Specific to Appropriate Use (AU), CDA-AMC has been tasked with driving a coordinated approach and a common agenda to improve patient safety and outcomes associated with prescribing and use of medications. To do this, CDA-AMC will finalize a pan-Canadian appropriate prescribing and use strategy and develop a corresponding program.
Appropriate use can be defined as follows:
Appropriate use is when patients, caregivers, and health care professionals work together to choose safe and effective medications most suited for that person's needs and goals to achieve best health outcomes. This can be subdivided into three main categories consisting of overuse, underuse and inappropriate use.
CDA-AMC’s AU program aims to spread promising appropriate use practices so they can benefit more people in Canada. To do this, we are launching a pan-Canadian Academic Detailing project. We are seeking a contractor who will support the evaluation of this project.
CDA-AMC is seeking a contractor to work collaboratively with CDA-AMC and the participating academic detailing organizations to build and implement an evaluation plan that demonstrates the impact of this project aligned to the 5 dimensions of quality that make up the Quintuple Aim (patient experience, population health, value for money, care team well-being and health equity). The project evaluation is intended to assess the effectiveness of this collaborative pan-Canadian initiative and its achievement of the project goals.
The successful contractor will produce the following:
- A project evaluation plan (and implementation of this plan)
- Mixed methods data collection tools
- Interim and final evaluation reports and presentation decks synthesizing findings from the project evaluation.
For more information, see the RFP Main Document.
